OTIC will continue to draw down its MC until anticipation for 2020 Ph3 Meniere's Disease trial kicks in. Presently, it is trading below Cash. But, there are at least 6 more Qs until the Meniere's trial reads out. Cash runway should extend into 2021. This is the second Ph3 in this indication. The first surprised by failing to differentiate from placebo.